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Rates for chronic obstructive pulmonary disease (COPD) have continued to increase, 
resulting in readmission tracking by the Centers for Medicare and Medicaid for 
community hospitals and Veterans Health Administration (VHA) hospitals. By using the 
Andersen healthcare utilization model as the theoretical framework, the purpose of this 
quantitative correlational research was to examine differences in 4,879 COPD 
readmission and mortality rates in VHA hospitals for the four Veteran Administration 
(VA) regional districts—Northeast, Southeast, Continental, and Pacific—as well as and 
between rural and urban VA hospitals. Secondary data was acquired from an open 
website through the Centers for Medicare & Medicaid Services. Using one-way analysis 
of variance (ANOVA) tests, Research Questions 1 and 2 addressed the four VHA regions 
concerning COPD mortality rates and readmission rates, but there were no statistical 
differences. An independent t test addressed Research Questions 3 and 4 to determine 
differences with COPD mortality and readmission rates in urban and rural VA hospitals, 
but again no statistical differences were found. Using a regression analysis, the fifth 
research question addressed 30-day readmission rates and 30-day mortality rates in urban 
and rural VA hospitals, which did show a significant association, as mortality rates were 
higher in urban rather versus rural VA hospitals. This study will promote positive social 
change by providing hospital administrators and researchers a clearer understanding of 
the concerns associated with COPD mortality rates in rural and urban VA hospitals. With 
this understanding, developing programs that address the unique needs of these 
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Section 1: Foundation of the Study and Literature Review 
Medicare penalties assessed on hospitals for readmissions increased to $528 
million in 2017, $108 million more than in 2016 (Boccutti & Casillas, 2017). A few 
causes affecting readmission rates are patient income levels, insurance type, social 
support, education, and language barriers (Mayr et al., 2017). A hospital readmission 
transpires when a patient is admitted to a hospital within a specified period after being 
discharged from an initial hospitalization. Medicare defines the readmission period as 30 
days and includes hospital readmissions to any hospital, not just the hospital at which the 
patient was formerly hospitalized, and for any hospital stay regardless of the reason for 
readmission (Centers for Medicare and Medicaid Services [CMS], 2015). This all-cause 
definition is used in calculating both the national average readmission rate and each 
hospital’s specific readmission rate (Boccuti & Casillas, 2017).  
The CMS considers many readmissions to be preventable and determined that the 
following be monitored: chronic obstructive pulmonary disease (COPD), chronic heart 
failure, diabetes, acute myocardial infarction, and pneumonia. These diagnoses are 
frequently seen when examining readmissions using CMS criteria (Mayr et al., 2017). 
COPD is a progressive lung disease that causes such symptoms as wheezing, coughing, 
chest tightness. Though smoking has been noted as the leading cause of COPD, there are 
other ways to develop the disease and of those diagnosed with COPD, 25% have never 
smoked (U.S. Department of Veterans Affairs, n.d.). Other causes of COPD have been 
linked to dust, chemicals, air pollution, and a genetic disease known as alpha-1 
antitrypsin l (U.S. Department of Veterans Affairs, n.d.). For example, many veterans 
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with COPD have participated in combat deployments and were exposed to potentially 
toxic lung irritants (U.S. Department of Veterans Affairs, n.d.). One study found that 
923,646 military personnel who served during Operations Enduring Freedom/Iraqi 
Freedom/New Dawn received VA health care between January 2002 through December 
2014 and 32,076 (3%) of the personnel had a coded diagnosis of COPD. Of the 32,076 
patients, 22,156 (69%) were identified as newly diagnosed COPD cases (Schneiderman 
et al., 2018). 
This research focused on whether there was significant difference between COPD 
readmissions and COPD mortality rates for veterans in the four administrative regions 
Veterans Administration (VA) Pacific District, VA Continental District, VA Northeast 
District, and VA Southeast District. Additionally, rural, and urban hospitals were 
assessed to determine whether there was a significant difference in relation to COPD 
readmissions and mortality rates.  
Problem Statement 
Readmissions have become a concern for hospitals, health care providers, 
insurance companies, government providers, military hospitals, and the CMS due to the 
costs associated with readmissions and the reason for readmissions—quality of medical 
care (CMS, n.d.). A few of the specifics related to readmissions may involve poor 
adherence of instructions with patient medications, lack of medical follow-up, and 
inadequate hospital discharge processes (Geboers et al., 2015). Lack of instructional 
education between care providers and patients has also been associated with an increase 
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in medical costs within many healthcare organizations as well as hospitals specific for 
veterans (Haun et al., 2015). 
Globally COPD has been considered one of the most common respiratory 
diseases (World Health Organization, 2019), which may be a cause for readmission. 
COPD is considered the 3rd leading cause of death in the United States and is thought to 
be increasing more quickly than other major illnesses (COPD Foundation, 2019). COPD 
among adults in the United States represents between 5.1% and 6.2% of the overall adult 
population, and in the veteran population, COPD is even higher ranking at 8.8% (Pyarali 
et al., 2018). Research has also shown that of deployed military personnel, 69% 
experienced respiratory symptoms and in 2011, those respiratory diseases, which 
included COPD, were accountable for over 250,000 medical encounters among active-
duty U.S. military personnel and further that COPD was the fourth leading cause for 
hospitalization among veterans (COPD Foundation, 2019).  
The higher rate in COPD among military personnel is thought to be due to 
smoking or tobacco use, which is often used as a coping mechanism to relieve stress, 
increase energy, and decrease appetite among military personnel (Pyarali et al., 2018). 
Additionally, mon-tuberculous mycobacteria is often diagnosed or thought to be part of a 
COPD exacerbation due to the common signs and symptoms between the two, but data 
among this population is limited, and even less is known about regarding the veteran 
population; however, there has been an increase in non-tuberculous mycobacteria rates 
since 2012 and an increased risk of mortality for veterans (Pyarali et al., 2018). Research 
has also shown that markers of COPD and emphysema were associated with veterans 
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living with HIV, making it important for follow-up and treatment for veterans with 
COPD and HIV as well as smoking cessation programs (Triplette et al., 2018).   
The Veterans Health Administration (VHA) oversees healthcare for those who are 
active duty and those who have retired from military service. The VHA is considered the 
largest unified healthcare system within the United States (U.S. Veteran’s Health Affairs, 
n.d.). Currently, the VHA is encountering many of the concerns within healthcare that 
non-VHA hospitals are facing such as readmissions, patient-centered care, education, and 
mortality rates (U.S. Department of Veterans Health Affairs, n.d.). But military personnel 
are faced with insurance options that may not always fit their needs. For example, they 
can have both Medicare coverage and insurance through the VHA; however, both 
insurances do not work together. For the VHA to cover, in most situations veterans are 
required to receive healthcare services at a VHA hospital. To receive Medicare benefits, 
veterans are required to receive healthcare services at a Medicare-certified facility 
(MedicareInteractive.org, 2015).   
Though many readmissions are unavoidable, some may occur due to poor quality 
of care or other factors (CMS, 2015). It is crucial that administrators are aware of 
methods to decrease healthcare costs by decreasing hospital readmissions not only within 
nongovernmental hospitals but also VA hospitals. Communication and attention to 
patients’ long-term care needs have come to the forefront as possible factors involved in 
hospital readmissions. For instance, chronic disease, including COPD, accounts for 20% 
of all Medicare hospital admissions and readmissions (McIlvennan et al., 2018). There 
have been studies associated with patient education but none related to COPD patients 
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readmitted to VHA hospitals and studied according to location (Bailey et al., 2015). 
Furthermore, there was a gap in literature pertaining to COPD readmissions and mortality 
for the different regions of the VHA hospital system (Balaban et al., 2015). This study 
addressed this research gap by exploring COPD readmissions and mortality for the four 
VHA regions and rural and urban hospitals. Knowledge gained could provide VHA 
administrators with information that would help them focus on ways to improve care and 
learn best practices in different areas of the country.  
Purpose 
The purpose of this quantitative correlational research was to determine whether 
there were statistically significant differences for COPD patient readmissions and 
mortality rates between the four VA regions and rural versus urban hospitals. By 
determining whether there were regional differences, the underlying reasons could be 
further assessed, and policies can be established to improve care. Decreasing 
readmissions could help hospital administrators by lowering healthcare costs and 
improving patient outcomes.  
The dependent variables were COPD readmissions and mortality rates. The 
independent variables were the four VA hospital districts and rural/urban hospitals within 
the United States. The secondary data were available for the regional districts through 
Medicare.gov. The VA is divided into four regional districts: Northeast, Southeast, 
Continental, and Pacific. The Northeast district consists of 18 states, Southeast district 
contains 13 states including Puerto Rico, the Continental district is comprised of 11 
states, and the Pacific district encompasses 11 states and the Philippines. Puerto Rico and 
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the Philippines were not included in the study. Additionally, a total of 126 urban and 
rural hospitals were included in this study. These data were available through the VA 
website and available to the public. 
Research Questions  
Research Question 1: Is there a significant difference between COPD mortality 
rates for veterans in the VA Pacific District, VA Continental District, VA Northeast 
District, and VA Southeast District? 
H01: There is no significant difference between COPD mortality rates for 
veterans in the VA Pacific District, VA Continental District, VA Northeast District, and 
VA Southeast District. 
Ha1: There is a significant difference between COPD mortality rates for veterans 
in the VA Pacific District, VA Continental District, VA Northeast District, and VA 
Southeast District. 
Research Question 2: Is there a significant difference between COPD readmission 
rates for veterans in the VA Pacific District, VA Continental District, VA Northeast 
District, and VA Southeast District? 
H02: There is no significant difference between COPD readmission rates for 
veterans in the VA Pacific District, VA Continental District, VA Northeast District, and 
VA Southeast District. 
Ha2: There is a significant difference between COPD readmission rates for 
veterans in the VA Pacific District, VA Continental District, VA Northeast District, and 
VA Southeast District. 
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Research Question 3: Is there a significant geographical influence for COPD 
readmission rates of veterans in urban and rural VA hospitals? 
H03: There is not a significant geographical influence with COPD readmission 
rates for veterans in urban and rural VA hospitals. 
Ha3: There is a significant geographical influence with COPD readmission rates 
for veterans in urban and rural VA hospitals. 
Research Question 4: Is there significant geographical influence with COPD 
mortality rates for veterans in urban and rural hospitals? 
H04: There is not a significant geographical influence with COPD mortality rates 
for veterans in urban and rural VA hospitals. 
Ha4: There is a significant geographical influence with COPD mortality rates for 
veterans in urban and rural VA hospitals. 
Research Question 5: Is there an association between 30-day readmission rate for 
COPD and the 30-day mortality rate? 
H05: There is no association between 30-day readmission rate for COPD and the 
30-day mortality rate. 
Ha5: There is association between 30-day readmission rate for COPD and the 30-
day mortality rate. 
Theoretical Framework 
The framework used for this research was based on the Andersen healthcare 
utilization model, which seeks to clarify factors that identify how individuals access 
health services (Babitsch et al., 2012; Hirshfield et al., 2016). The four factors of this 
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model are environment, population characteristics, health behaviors, and outcomes 
(Babitsch et al., 2016). The first factor, environment, plays an important role in the 
beginning phases of care because of issues such as the healthcare system near patients as 
well as the external environment related to air and water safety (Babitsch, et al., 2016). In 
this study, this factor applied to the location of the hospital (urban vs. rural). The next 
factor is population, which includes a patient’s predisposing characteristics and the 
resources available. Predisposing characteristics are things such as social factors like 
education, occupation, ethnicity and contextual factors like demographic and social 
compositions of the surrounding community, the values, and what is acceptable or 
considered to be cultural or political norms (Hirshfield et al., 2016).  
The third factor within the model is known as health behavior. Health behaviors 
are impacted by health experiences such as a person’s perceived idea of what their 
healthcare needs are and whether they are derived from one’s own experiences or the 
community which surrounds that person (Hirshfield et al., 2016). The final factor is 
known as outcomes and pertains to a person’s health practice and their use of health 
services. This phase is made of perceived health status, evaluated health status, and 
overall consumer satisfaction (Hirshfield et al., 2016).  
Anderson’s behavioral model, as seen in Figure 1, has been used extensively in 
studies to show a framework of how patients and environmental factors can impact a 
patient’s behaviors and outcomes (Babitsch et al., 2012). Andersen’s behavioral model 
was used in a study involving Appalachian women who were considered to be from 
vulnerable populations and substance abuse treatment. The study provided contributing 
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research to social work addiction literature as well as highlighting the importance of 
understanding the role of cultural factors treatment utilization among Appalachian 
women (Victor et al., 2017). Additionally, Li et al. (2016) used the model in the study to 
show the impact of disposing, qualifying, and needs for health services among the rural 
populations in Guangxi, China. Chronic diseases were observed along with the 
association of health service utilization. Important predictors were age, gender, marital 
status, family size and education level. The study found factors that contributed to 
hospitalization: travel time to the nearest health facility, utilization of physician visits, 
and healthcare expense.  
Figure 1 
 
Flow Process Used in Anderson’s Behavioral Model 
 
Since the Andersen healthcare utilization model is frequently used in healthcare 
studies to show equitable and inequitable relationships concerning patients and their 
healthcare services, this model relates to this research concerning how VA administrators 
may manage COPD patients to more effectively reduce readmissions. Furthermore, many 
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veterans have adjustment issues related to their environment after they leave active duty 
and often a lack of understanding about how to access services and the environmental 
issues associated with the model relate to this concern (Hirshfield et al., 2016).  
Possible Analytic Strategies  
One possible statistical test suitable for this study was the t test, which involved 
evaluating data values. This test can be used for paired or unpaired groups and assesses 
whether the means between the two groups are statistically different from one another 
making it appropriate to be used with randomized studies (Social Research Methods, 
2019). Another statistical test used was the ANOVA. An ANOVA tests the significant 
differences between groups to assist in accepting or rejecting the null hypothesis (How 
To Statistics, 2018). The ANOVA helps to decrease the chance of a Type 1 error—falsely 
concluding significance when there is no real effect present. The ANOVA was 
appropriate in my study as it has been used in similar studies to test if one treatment is 
more effective than another in a certain sample population. By applying ANOVA testing 
to secondary data sets, the researcher can see the generalizations of groups that differ, but 
not specifically which groups (du Prel et al., 2010). By using ANOVA in this study, I 
tested the significance of the differences between COPD readmission rates for veterans in 
the VA Pacific District, VA Northeast District, VA Continental District, and the VA 
Southeast District. Additionally, a regression analysis was used to determine whether 
there were significant differences in COPD readmissions and mortality rates in urban and 
rural hospitals.  
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Literature Review Related to Key Variables and Concepts 
The purpose of this literature review was to report on articles related to the topics 
of this research. These topics included a systematic focus on the variables associated with 
this study: COPD 30-day readmissions and mortality rates in veteran hospitals in four 
U.S. regions. COPD is considered one of the most common respiratory diseases. Among 
adults in the United States, COPD represents between 5.1 and 6.2% of the overall adult 
population and in the veteran population, COPD is even higher ranking at 8.8% (Pyarali 
et al., 2018). The articles in this section support the problem, purpose, and scope of this 
study.  
Literature Search Strategies 
Articles were found by using Walden University online library databases 
including ProQuest, PubMed, Science Direct, Sage, National Institutes of Health, and 
MEDLINE, and ICPSR. Google Scholar and Research Gate were also used. Search 
strategies included peer-reviewed literature since 2014 and prior seminal literature by 
using key search words readmissions, COPD, VA readmissions, Veterans Hospitals, 
mortality rates, outcomes, chronic illness, chronic disease, and Hospital Readmission 
Reduction Program (HRRP; CMS, n.d.).  
Military Health System 
Many of the Military Health System hospitals and clinics can improve their 
productive effectiveness (Bastian et al., 2016). Best practices from the Army should be 
shared with the other service branches, as research has found no association between 
efficiency and wellness over time in the Military Health System (Bastian et al., 2016).   
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Costs and Social Attributes 
Federal spending on health care is expected to rise by 20% by 2050, and as of 
2011, total health care spending exceeded $2.7 trillion (Bastian et al., 2016). As with the 
national trends in health care costs, the Military Health System budget increased from 
$19B in 2001 to $49B in 2014. Contributing factors associated with increased health care 
costs in military hospitals include decreasing eligibilities of healthcare services, 
treatments, or programs for retirees, and more than a decade of expanding personnel 
levels and deployments (Bastian et al., 2016).   
Another reason for rising healthcare costs is that the VA system has performed 
worse in the area of readmissions despite performing the same or better as non-VA 
systems when it comes to quality measures (Wray et al., 2019). Readmission rates may 
differ due to social characteristics frequently not added in readmissions models (Wray et 
al., 2019). For instance, veterans who utilize VA care tend to have a lower education 
level and are less likely to have employment, which is information not applied in CMS 
readmission models reasoning that social risk factors may play a role in hospital (Wray et 
al., 2019).   
Veterans Hospitals 
Over the past 25 years improving quality of care has been the focus of the 
Department of VA healthcare system (Segal et al., 2019). The VA has made efforts to 
improve quality throughout its national system; however, there is evidence that health 
outcomes vary between VA hospitals across the United States. Such evidence was 
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identified as factors like quality-of-care culture of data collection, feedback, and behavior 
change as well as process-of-care measures (Segal et al., 2019).   
Congestive Obstructive Pulmonary Disease  
COPD Military 
 COPD has been the third leading cause of morbidity and mortality among non-
military personnel as well as a common cause of illness and death among veterans, who 
may be at a higher risk for COPD than non-military (COPD Foundation, 2019). Since 
2001 more than 2.7 million U.S. military personnel were deployed to Southwest Asia and 
Afghanistan (Garshick et al., 2019). During deployment military personnel were exposed 
to elevated amounts of particulate matter and other inhalational exposures from multiple 
sources, including desert dust, burn pit combustion, and other industrial, mobile, or 
military sources, increasing the chance of military personnel developing COPD (Garshick 
et al., 2019).  
COPD Outcomes for Veterans 
Studies have examined the 30-day risk-standardized readmission rates and 
hospital profiling within the VHA. Based on 3 years of data from VA hospitals, one study 
found an increasing number of facility admissions, and four hospitals had risk-
standardized readmission rates worse than the national average for patients seen with 
acute myocardial infarction, heart failure, and pneumonia. Using the readmission 
measure created by the CMS may not be a useful tool to extricate performance or to drive 
quality improvements for readmissions (Wray et al., 2019).  
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Further, clinical trials have shown some patients with chronic conditions such as 
diabetes or COPD do not obtain, accept, or follow recommended care. This lack of 
adherence along with an increase in the aging population, increased comorbidities, and 
social differences or gaps within communities with chronic health conditions amplifies 
the need for health focus within the health care setting (Carter et al., 2018). The high 
incidence of chronic health conditions along with increases in hospital readmissions has 
led researchers to investigate instances of patient navigation using resources beyond the 
hospital visit to assess the various factors involved in patient care that may also affect 
hospital readmissions. Undesirable health-related outcomes such as poor physical health, 
poor fitness, increased rates of hypertension, arthritis, and mortality have been strongly 
associated with low health literacy (Geboers et al., 2015), which impacts all types of 
hospitals. Demographic and epidemiological transitions have also had an impact on 
chronic disease, including COPD, with the aging population. With an increase in life 
expectancy, a large portion of the elderly population suffers from some type of chronic 
illness or disease, leading to an increase in exacerbations with their disease or condition 
as well as an increase in mortality (Damiani et al., 2015). 
Signs and Progression of COPD 
There are four main stages of COPD that range from mild, moderate, severe, and 
very severe. Though pulmonary function tests, commonly referred to as a spirometry or 
lung function test, were thought to be the best way to predict if a person had COPD, 
today caregivers not only focus on the patients pulmonary function tests but also factor in 
such things as shortness of breath, cough, oxygen levels, stretched out or larger lungs, 
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and chronic conditions in addition to the COPD (COPD Foundation, 2019). Currently 
there is no cure for COPD; however, there are many treatments, management strategies, 
and guidelines recommended by both the American Association of Respiratory Care 
Practice Guidelines and the American Thoracic Society Clinical Practice Guidelines 
(Global Initiative for Chronic Obstructive Lung Disease, 2019).  
COPD exacerbations have been noted as the natural disease process in which a 
sudden event causes more sputum, coughing, and shortness of breath than the patient’s 
normal baseline (Global Initiative for Chronic Obstructive Lung Disease, 2019). 
Exacerbations have both short- and long-term clinical consequences, causing a huge 
burden on the healthcare system worldwide—making up over 50% of the total health care 
costs for COPD—as well as being a leading factor in morbidity (Qureshi et al., 2014). 
Exacerbations continue in frequency as the disease process progresses; each exacerbation 
brings less lung function and eventually reduced physical activity (Qureshi et al., 2014). 
Health Disparities Associated with COPD 
Research has indicated multiple factors that may lead to COPD rates. The 
worldwide problem of COPD has been growing due better outcomes for other diseases, a 
high population who have been exposed to toxic inhalants, and socioeconomic status 
(Pleasants et al., 2016). Differences in health behaviors, sociopolitical factors, and social 
and structural environmental exposures also impact COPD. For instance, the use of 
tobacco, occupations with toxic inhalants, and indoor biomass fuel exposure have a 
higher rate of COPD (Pleasants et al., 2016). According to the World Health 
Organization (2017), 90% of deaths in COPD patients occur for those in low-income and 
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middle-income countries. Other research has noted similar findings regarding low 
socioeconomic status being a factor with COPD disease. In a study on China, though 
health insurance coverage reached 99% in Taiwan, within rural villages the access to 
health care was still low, and it was even lower among the mountainous aborigines who 
also had an increase in mortality rates (Chan et al., 2014). Further, Burkes et al. (2018) 
found that many COPD patients in rural areas were employed by facilities that 
manufactured synthetic-fibers, pig farms, carpenters, agricultural businesses, and beauty 
care, causing regular contact with different types of fine dusts such as wheat flour, animal 
feed or grain, metal, cotton dust, or fumes (Burkes et al., 2018). For veterans, there has 
been an increase in veteran outpatient use of chronic opioid therapy, especially for those 
younger, White, female, and living in the rural United States; COPD was the most 
common diagnosis for those in the program 6 months prior to hospital admission (Mosher 
et al., 2014).  
30-day Readmissions 
Reasons and CMS Penalties 
When a patient has been discharged from a healthcare facility and returns within 
30 days of the initial discharge, it is considered a readmission, which are often costly, 
unforeseen, and even avoidable (CMS, n.d). Due to the exorbitant price of these 
readmittances the CMS frequently imposes fees on healthcare facilities. Many times, 
patients are diagnosed with a specific type of disease and then a different reason for a 
return visit (CMS, n.d.). For example, a patient with a diagnosis of COPD has been 
discharged from the hospital only to return 7 days later due to his/her diabetes. It is 
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possible the hospital focused only on treatment for the COPD and not the diabetes, yet 
after discharge weather temperatures, eating habits, and other issues could have 
contributed to the diabetes causing a readmission.   
The American Care Act (ACA) included a clause assigning penalties for patient 
readmissions 30 days after discharge (CMS, n.d.). This program is a Medicare value-
based plan which reduces healthcare facility payments, based on increased readmissions. 
By linking health care payments to health care quality, the program supports the national 
goal of improving health care (CMS, n.d.). Given the high impact of patient load on 
healthcare systems, COPD was added to the Medicare Hospital Readmission Reductions 
Program in 2015, resulting in financial penalties for COPD readmissions within 30 days 
of hospital discharge (Portillo et. al., 2018).  
Contributing Factors for Readmissions 
Contributing factors to patient readmissions are believed to be concentrated 
around such factors as literacy, self-management, patient understanding, and education 
given by the healthcare providers. For instance, increased readmissions have shown an 
increase with poor self-management (Powell & Kripanlani, 2017). Another possible 
factor that contributes to readmissions is the concern regarding patients who suffer from 
psychiatric or behavioral health needs (Balaban, et al., 2015). Recommendations to help 
patients understand their medications and instructions include using simple language, 
practicing teach back methods, demonstration of the use of assistive devices, providing 
visual medication schedules, pictographs, and other multimedia aids. Powell & 
Kripanlani (2017), recognized many physicians tend to overestimate their patients’ 
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literacy level, therefore increasing the need for improvements in patient advocacy and 
education.    
30-Day Readmissions for Veterans 
According to an article by Portillo et al., (2018), in a coast-to-coast evaluation of 
Medicare claims, only 50% of patients readmitted have a primary care physician (PCP). 
Ambulatory care practitioners with the US Department of Veterans Affairs (VA) health 
care system are integrated into patient aligned care teams. Each care team is comprised of 
team members such as a primary care physician, pharmacist, registered nurse, social 
worker, respiratory therapist, or other healthcare provider. Each team member provides a 
different area of need for the patient such as patient education, chronic disease 
management, and medication optimization, and each team member contributes their 
unique training and expertise preparing the patient for their follow-up visit within 30 days 
of their hospital discharge (Portillo et al., 2018). Thirty-day readmission rates of 22.6% 
were found for patients with COPD.  
The VHA works in partnership with the CMS to provide patients information 
about the quality and safety of the care received (CMS, 2016). Of Veterans enrolled 
within the VA healthcare system, about 50% are eligible for Medicare services. These 
services also allow the patients to have some decision allowance with such concerns as to 
how and where they accept and obtain inpatient services (CMS, 2016). 
Readmissions rates have shown a substantial increase in primary care service 
areas among patients with multiple chronic conditions in non-Veteran’s hospitals (Basu, 
2015). Another study by (Herrin et al., 2015), found a significant relationship between 
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readmissions of patients diagnosed with acute myocardial infarction, pneumonia, and 
heart failure and the location of their hospital within the county demographics. According 
to (Nuti, 2016) a comparison study between non-VA hospitals and VA hospitals showed 
VA hospitals had higher rates for both readmissions and mortalities for acute myocardial 
infarctions, pneumonia, and heart failure.    
Coordination of Care for Veterans 
In a study by (Cordasco, et al, 2019), authors examined improving care 
coordination for veterans. Care coordination was described as assisting patients with 
navigating healthcare services within the VA system and non-VA systems to receive the 
need care without duplicating care or services and by avoiding missed opportunities. It is 
well understood that coordinating care is crucial for improving patient health, outcomes, 
experiences, decreasing costs, and patient surveys. It is also understood many Veterans 
have more than one specific condition contributing to ailing health (Cordasco, et al, 
2019). A State of the Art (SOTA) conference was held in March of 2018, supported by 
the VA Health Services Research and Development (HSR&D) service and the VA’s 
Office of Primary Care as well as the Office of Community Care. Goals of the conference 
were (a) examining care coordination relevant to Veterans’ care; (b) distinguishing care 
coordination approaches; and (c) identifying a research agenda and recommendations, for 
increasing VA’s knowledge and use of evidence-based approaches (Cordasco, et al, 
2019). Findings from the study suggest further coordinating efforts between researchers, 
VA, and non-VA providers to work together to collectively achieve strategies and 
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frameworks to make available patient experiences to maximizes safety, quality, and 
efficiency (Cordasco, et al, 2019).  
In another study by Herbert and Chuan-Fen, (2015), assessed readmission rates 
and costs for HF and COPD, two of the more common readmission diagnoses reported. 
Datasets examined were comprised of VA administrative datasets, non-VA medical care 
data, Medicare claims and facility surveys of clinical practices for HF (Herbert & Chaun-
Fen, 2015). Factors examined within a year after the initial admission were healthcare 
costs including VA, fee-basis, and Medicare costs, self-reported by either the chief of 
medicine, cardiology, or pulmonology, heart failure or COPD focus clinics, programs and 
activities, standardized orders, performance measures, and clinical reminders, as well as, 
discharge practices and follow-up which include quality measures, patient education, 
follow-up calls, and scheduling of a follow-up visit (Herbert & Chaun-Fen, 2015). The 
impact of the study found that the burden of readmission costs of HF and COPD are quite 
substantial. Factors found resulting in lower readmission rates were facilities which had 
patient focused education and hospitalists which actively practiced at the facilities 
(Herbert & Chaun-Fen, 2015).  
Costs of Hospital Readmissions 
For the fiscal year 2018, CMS has reported 2,573 for non-VA hospitals will face 
reduced reimbursement from Medicare under the Hospital Readmissions Reduction 
Program (HRRP) (Rau, 2019). Other statistics show $564 million in payments will be 
withheld by CMS under HRRP, which is an increase from 2017 (Rau, 2019).  
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Non-VA hospital readmission costs have reached 41.3 billion for patients 
readmitted 30 days have discharge with Medicare beneficiaries contributing to $26 
billion annually and $17 billion of those are unnecessary (Agency for Healthcare and 
Research Quality, 2018). In 2017, CMS penalized over 2,500 hospitals by more than 
$564 million for excessive 30-day readmissions (Agency for Healthcare and Research 
Quality, 2018). According to the Agency for Healthcare and Research Quality (2018), top 
areas contributing to 30-day readmissions in 2017 were congestive heart failure with 
134,500, septicemia with 92, 900, pneumonia with 88,800, COPD and bronchiectasis, 
with 77,900 and cardiac dysrhythmias with 69,400 readmissions. According to Carey and 
Stefos (2016), administration could expect to save $2140 for the average 30-day 
readmission prevented. Estimated cost savings for heart attacks, heart failure, and 
pneumonia patients, were $3432, $2488 and $2278 (Carey and Stefos, 2016). 
Urban Versus Rural VA Hospitals 
One study examined the diagnosis and management of COPD care between urban 
and rural VA hospitals in Minneapolis, Minnesota. It was noted that fewer rural hospitals 
were able to provide spirometry testing for COPD patients as well as recognizing fewer 
COPD patients had prior spirometry testing ever compared to their counterparts. 
However, many rural hospital clinics were in the beginning process of implementing on-
site spirometry with a centralized interpretation and quality control (Swanson, Westanmo, 
Rector, Rice , and Duane, 2016).  
In another study, findings revealed rural patients used VA hospitals more than 
urban if they lived in the South, but they used VA hospitals less in other states. Results 
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from the study also showed rural VA patients were hospitalized less often for mental 
disorders except for respiratory diseases and revealed very rural patients relied on VA 
hospitals more than urban patients (West, Weeks, and Charlton, 2015). 
Gap in Literature 
While there were many studies related to 30-day hospital readmissions, including 
COPD readmissions, there was a gap in the literature associated with readmissions and 
mortality rates among V.A. hospital patients. To address this gap, secondary data for 
COPD patients from V.A. hospitals in the four VHA districts was addressed and analyzed 
in this study. COPD is considered the third leading cause of death in the U.S. and is 
increasing along with other major illnesses in both general and military populations 
(Triplette, Justice, and Attia, et al., 2018). 
Conclusion of Literature Review 
A thorough literature review was conducted concerning articles about COPD 30-
day readmissions and mortality rates in V.A. hospitals. Literature supports COPD as one 
of the largest causes for readmissions in healthcare; however, there was a literature gap 
when analyzing V.A. hospitals. The literature review described multiple articles 
concerning many aspects of readmissions and COPD and described an important health 
care problem that needs to be addressed on many levels. Readmissions have become a 
concern for hospitals, health care providers, insurance companies, government providers, 
military hospitals, and the CMS (CMS, n.d.). The literature emphasizes that COPD is 
considered one of the most common respiratory diseases. COPD among adults in the US 
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represents between 5.1 and 6.2% of the overall adult population and in the Veteran 
population, COPD is even higher ranking at 8.8% (Pyarali et al., 2018).  
Definitions 
For the purpose of this study, the following terms were defined: 
30-day Readmissions: An unintended hospital admission for a person who was 
discharged within 30 days prior from a previous hospital admission. (Mayo Clinic, 2017).  
Chronic Obstructive Pulmonary Disease (COPD): An inflammatory disease-
causing obstructive airflow from the lungs. Exposure to inhalants such as chemical, 
particulate matter such as dust, irritating gases, and smoking have been known to cause 
COPD (Mayo Clinic, 2017). 
Mortality: Death resulting from a specific illness, disease, or cause. Data indicates 
numbers of death by place, time, and cause (World Health Organization, 2019).  
Socioeconomic Status: Position, ranking or social classification of an individual 
or groups of people. Often measured by education, income, and/or occupation (American 
Psychology Association, 2019).  
VA Regions: There are currently four districts: Northeast, Southeast, Continental, 
and Pacific. Each region is comprised of multiple states and each state is comprised of 
specific VA Hospitals (U.S. Department of Veterans Affairs, n.d.). 
Veterans Affairs Hospital: A hospital facility designated by the VHA to evaluate 
and treat veterans specifically (U.S. Department of Veterans Affairs, 2021). 
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Assumptions   
An assumption is defined as being an unexamined belief and the following 
assumptions relate to this study (Ekstom Library, 2019). One assumption was that COPD 
readmissions and mortality rates for all VA hospitals regions were the same in hospitals 
throughout the United States. A second assumption was that data gathered from the CMS 
website was an accurate predictor of readmissions and mortality rates among VA hospital 
regions within the U.S. (CMS.gov., n.d.). A final assumption was that all VA hospitals 
submitted correct information about COPD readmissions and mortality rates and that 
information in the secondary data set was accurate.  
Limitations 
Limitations are common in all types of research studies and are often beyond the 
researcher’s control. This is typically related to model constraints, research design, or 
funding (Theofanidis & Antigoni, 2019). Readmission and mortality rates are obtained 
from the CMS patient data, which was limited to data for patients who are 65 years of age 
and older (Burke, Frakt, Khullar, Orav, & Jha, 2017). Possible constraints such as time, 
funding, and access to the populations of the study are unknown.  
Scope and Delimitations 
The scope of this study was to understand if VA hospital regions differ in relation 
to COPD readmissions and COPD mortality rates for veterans in the VA Pacific District, 
VA Continental District, VA Northeast District, and VA Southeast District. Additionally, 
126 urban and rural VA hospitals were included in this study; this data was available 
through the VA and available to the public. This specific focus was chosen because these 
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factors were key components for quality of care and improved patient outcomes for VA 
hospitals regionally.  
Delimitations are defined as boundaries which the research establishes and are 
within his or her control. These boundaries are focused on the study’s theoretical 
background, objectives, research questions, and variables (Theofanidis & Antigoni, 
2019). Delimitations for this study were limited to the use of data comparisons between 
VA hospitals. Secondary data was extracted from public datasets and analyzed as 
presented without manipulation. Unknown conditions could influence variability with 
responses given upon interviews, visits, and surveys (Wargo, 2015).   
Significance, Summary, and Conclusion 
Through careful examination of COPD readmissions and mortality rates within 
VA hospitals, this study potentially provided a better understanding of the effects of 
COPD 30-day readmissions and mortality rates and contribute to advancing healthcare 
practices, knowledge, and understanding by healthcare administration. Both readmissions 
and costs are possibly affected by demographical regions. It is estimated there are more 
than 35,000,000 hospital readmissions each year, based on the 36% rule, 12,600,000 of 
these admissions (Leuck, 2017). Readmissions are currently a primary focus in healthcare 
and with more emphasis on patient-centered care, increased medical costs, and patient 
choices it is important to analyze if there are differences within VA hospitals regionally. 
Understanding COPD 30-day readmissions and mortality rates in VA hospitals will help 




Section 1 introduced the problem of regional differences in COPD readmissions 
for VA Hospital patients. This section defined the introduction, the nature of the study, 
definitions, assumptions, scope and delimitations, limitations, and significance of the 
study. Section 2 explored the research questions further in terms of the variables 




Section 2: Research Design and Data Collection 
Readmissions have been a concern for hospitals, health care providers, insurance 
companies, and government providers, which include military coverage and the CMS, 
due to the high cost of health care services (HRRP, 2018). Additionally, readmissions 
involve poor adherence to instructions with patient medications, lack of medical follow-
up, and inadequate hospital discharge processes (Geboers et al., 2015). Andersen’s 
behavioral model of health care utilization provided a foundation for this research 
examining differences among regional groups regarding COPD readmissions and 
mortality based on COPD readmissions in this study. In this section, I describe the 
research design, methodology, and analytical tools that were used to address the research 
questions. 
Research Design and Rationale 
The purpose of this quantitative study was to examine possible differences in 
COPD readmissions and mortality based on COPD readmissions among veterans in the 
VA regions and urban/rural locations. Decreasing readmissions may help hospital 
administrators by lowering health care costs and improving patient outcomes. The 
dependent variables were COPD readmissions and mortality rates, and the independent 
variables were the four VA hospital districts and rural/urban hospitals within the United 
States. A quantitative analysis was appropriate for this study due to the secondary data 





All states that reported data concerning COPD readmissions and mortality rates 
were included in the study. Three states did not report any data: New Hampshire, Alaska, 
and Hawaii. The 47 states included in the study had the data elements related to 
hospitalization of veterans in a VA hospital within one of the four U.S. VA regions, 
COPD 30-day readmissions rates, and COPD mortality rates related to readmissions. 
Figure 1 provides an illustration of these four divisions. 
Figure 2 
 
Veterans Administration Regional Districts 
 
Note. From “Regional Offices Websites,” by U.S. Department of Veterans Affairs, n.d. 




Sampling for VA Regions: Research Questions 1 and 2 
The sample included data from the 47 states that provided information to the 
CMS. This sampling was relevant considering COPD affects over 11 million Americans, 
and occurrence of the disease was thought to be 3 times higher for the veteran population 
(Portillo et al., 2018). VA regional districts consist of four districts that provide services 
and address issues, problems, concerns within the districts. Table 1 provides an 
illustration of these four regions as well as information pertaining to the study population. 
The CMS data for this study consisted of patients from 275 VA hospitals with a diagnosis 
of COPD. The data also consisted of mortality rates for the same VA hospitals (U.S. 
Department of Veterans Affairs, 2021). The secondary data were collected between July 
1, 2015 to June 30, 2018.  
Table 1 
 
Veterans Administrative Regions with Mortality and Readmission Rates July 1, 2015 to 
June 30, 2018 
VA Administrative 
Regions 






Northeast 17 11,002 9,713 
Southeast 12 10,972 9,687 
Continental 11 4,864 4,358 
Pacific 10 5,478 5,102 
Total Population 50 32,316 28,860 
Note. Data are from U.S. Department of Veterans Affairs (2021). 
Sampling for VA Rural and Urban Hospitals: Research Questions 3 and 4 
The sample included data from the 126 rural and urban VA hospitals. The 
hospitals were chosen randomly from each administrative region and based on similar 
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sizes of the rural hospitals. The data were open-sourced data from Medicare.gov and are 
categorized in Table 2.  
Table 2 
 
Veterans Administrative Hospitals’ Mortality and Readmission Rates July 1, 2015 to 











States with Rural 
VA Hospitals 
15 15 rural Hospitals 2,201 1,998 
States with Urban 
VA Hospitals 
45 100 urban hospitals 
(15 were chosen 
hospitals of similar 









Note. Data are from U.S. Department of Veterans Affairs (2021) 
*The states do not total 50 as this information concerns how many of the states have urban and 
rural hospitals and several have both.  
**15 urban hospitals will be chosen that have similar bed sizes to the rural hospitals.  
***The number of patients for rural and urban hospitals will be similar once the hospitals are 
chosen. Therefore, the number of patients for urban hospitals are an approximation.  
 
Methodology: Secondary Data 
The secondary data set pertaining to COPD readmissions and mortality rates 
within VA hospitals were obtained from the Department of Veterans Affairs. This 
information was available to the public and did not require special permission (CMS, 
2019). A quantitative analysis was conducted to analyze the data and to provide a 
systematic investigation into the understanding of the differences, if any, between COPD 
readmissions and mortality rates among the four VA regional hospitals. The dependent 
variable was COPD readmissions and mortality rates. The independent variables were the 
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four VA hospital regions within the United States and urban and rural hospitals. Hospitals 
that were designated as rural and urban are located on the VA website (VHA.org). 
Research Questions and Hypotheses 
This study included the following research questions and corresponding 
hypotheses: 
Research Question 1: Is there a significant difference between COPD mortality 
rates for veterans in the VA Pacific District, VA Continental District, VA Northeast 
District, and VA Southeast District? 
Ho1: There is no significant difference between COPD mortality rates for veterans 
in the VA Pacific District, VA Continental District, VA Northeast District, and VA 
Southeast District. 
Ha1: There is a significant difference between COPD mortality rates for veterans 
in the VA Pacific District, VA Continental District, VA Northeast District, and VA 
Southeast District. 
Research Question 2:  Is there a significant difference between COPD 
readmission rates for veterans in the VA Pacific District, VA Continental District, VA 
Northeast District, and VA Southeast District? 
Ho2: There is no significant difference between COPD readmission rates for 
veterans in the VA Pacific District, VA Continental District, VA Northeast District, and 
VA Southeast District. 
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Ha2: There is a significant difference between COPD readmission rates for 
veterans in the VA Pacific District, VA Continental District, VA Northeast District, and 
VA Southeast District. 
Research Question 3:  Is there a significant geographical influence for COPD 
readmission rates of veterans in urban and rural VA hospitals? 
Ho3:  There is not a significant geographical influence with COPD readmission 
rates for veterans in urban and rural VA hospitals. 
Ha3:  There is a significant geographical influence with COPD readmission rates 
for veterans in urban and rural VA hospitals. 
Research Question 4:  Is there significant geographical influence with COPD 
mortality rates for veterans in urban and rural hospitals? 
Ho4:  There is not a significant geographical influence with COPD mortality rates 
for veterans in urban and rural VA hospitals. 
Ha4:  There is a significant geographical influence with COPD mortality rates for 
veterans in urban and rural VA hospitals. 
Research Question 5: Is there an association between 30-day readmission rate for 
COPD and the 30-day mortality rate? 
H05: There is no association between 30-day readmission rate for COPD and the 
30-day mortality rate. 
Ha5: There is association between 30-day readmission rate for COPD and the 30- 
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Data Analysis Strategies      
The quantitative analysis, using correlational statistics, analyzed whether VA 
hospitals in the four regions shown a difference with COPD readmissions or mortality 
rates. Data was displayed in tables, graphs, or charts. Regression analysis was used as an 
analysis strategy. 
Additionally, a statistical test was used in the ANOVA. An ANOVA is used to 
test the differences between groups to assist in accepting or rejecting the null hypothesis 
(Statistics, How To, 2018). The ANOVA helps to decrease the chance of a type 1 error, 
which is falsely concluding significance when there is no real effect present. The 
ANOVA was appropriate in this study because it had been used in similar studies to 
determine whether one treatment was more effective than another in a certain sample 
population. By applying ANOVA testing to secondary data sets, the researcher can 
determine the differences among groups (Prel, Röhig, Hommel, & Blettner, 2010). 
Another statistical test suitable for this study was the t-test, which involved evaluating 
data values. This test can be used for paired or unpaired groups. Additionally, a 
regression analysis was used to determine if there were significant geographical 
influences with COPD mortality rates for veterans in urban and rural hospitals.  
Power Analysis and Sample Size Estimation 
Four VA Administrative Regions: Power Analysis for Readmission Rates 
A statistical analysis was performed to determine the appropriate sample size for 
the study. Determining the minimum sample size enhanced the validity of the analysis. I 
used a statistical calculator designed to perform this task (Creative Research Systems, 
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2012). Calculations included a confidence level of 95%. The confidence interval was 5 
and the population was 32,316 patients admitted with COPD to VA hospitals in the four 
districts between July 1, 2015 and June 30, 2018. This analysis indicated that a minimum 
of 380 patients would be needed for the first research question. I will use the total 
population of 32,316 patients with COPD to analyze the data.  
Four VA Administrative Regions: Power Analysis for Mortality Rates 
A statistical analysis was performed to determine the minimum sample size for 
the second research question. Determining the minimum sample size enhanced the 
validity of the analysis. I used a statistical calculator designed to perform this task 
(Creative Research Systems, 2012). Calculations included a confidence level of 95%. The 
confidence interval was 5 and the population was 28,860 COPD patient mortality rates in 
VA hospitals in the four districts between July 1, 2015 and June 30, 2018. This analysis 
indicated that a minimum of 379 patients would be needed for the second research 
question.  
Power Analysis for Urban and Rural VA Patients  
A statistical analysis was performed to determine the minimum sample size for 
the third and fourth research questions based on the Medicare data. Determining the 
minimum sample size enhanced the validity of the analysis. I used a statistical calculator 
designed to perform this task (Creative Research Systems, 2012). The rural totals for the 
categories are 1,928 patients for mortality and 2201 patients for readmissions. Similar 
numbers were randomly chosen for urban regions using hospitals of similar sizes (U.S 
Department of Veterans Affairs, (2021). Therefore, the total estimates were 3,856 for 
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COPD VA mortality patient events and 4402 for VA COPD patient readmissions. 
Calculations included a confidence level of 95%. The confidence interval was 5 and the 
population was 3,856 for COPD patient mortality rates in VA hospitals and COPD 
patient readmission rates of 4,402 between July 1, 2015 and June 30, 2018. This analysis 
indicated that a minimum of 35 patients would be needed for the third and fourth research 
questions.  
Data Collection and Management 
After the proposal and oral presentation were approved, Walden University’s 
Institutional Review Board (IRB) conducted a review of the secondary data. The 
application (Form A) was submitted to the IRB staff along with other required forms and 
communication until all requirements were met, and the information met the university’s 
ethical expectations. The data analysis did not begin until after the IRB committee had 
provided approval and permission to proceed.  
Threats to Validity 
Internal Validity 
Patient misdiagnosis could be an internal threat to the validity of the CMS data 
used for this study. Diagnosis of patients upon discharge or death may or may not be 
correct due to data availability. Accuracy of the 2018 data was dependent on what was 
reported to CMS from the participating VA hospitals.  
External Validity 
Secondary data for this study originated from data collected through the CMS. 
The study was population based and sorted by VA hospitals, states, COPD readmission, 
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and mortality, which was applicable because COPD is a 30-day risk measurement 
required by CMS (2019). The COPD readmission and mortality data were limited to VA 
hospital patients.  
Ethical Considerations 
The data collected from the 2018 CMS study were contained in a public use site, 
and secondary data had been patient de-identified to ensure that there were no risks 
associated with confidentiality of protected health information. Data collected for the 
study was downloaded and stored to my personal computer and deleted upon study 
completion.   
Summary 
In Section 2, I described the proposed study design and collection methods to 
determine whether there is a difference between 30-day readmission and mortality rates 
among VA hospital districts and between urban and rural VA hospitals. Section 2 also 
included the proposed methodology. Section 3 provides the statistical results related to 





Section 3: Presentation of the Results and Findings 
COPD is the third leading cause of death, and readmissions have become a 
concern (CMS, n.d.). The primary purpose of this quantitative study was to determine the 
association between COPD readmissions and mortality rates by examining the 
relationship between rural and urban VA hospitals within the four VA regions within the 
United States. The research questions addressed whether there was a difference among 
mortality and readmission rates for veterans in the four VA regions and between rates for 
urban and rural hospitals as well as whether there is an association between 30-day 
readmission rates for COPD and 30-day mortality rate. Characteristics of the secondary 
data used for this study were VA patients with a COPD diagnosis or VA patient’s death 
considered to be COPD related. Individualities such as age, race, gender, and insurance 
were not applied as it did not pertain to this study; however, these could be beneficial in 
future studies. Geographical location of hospitals used for secondary data were VA 
hospitals within the Continental, Pacific, Northeast, and Southeast districts within the 
United States and comprised of both rural and urban inhabitants.  
Data Collection of Secondary Data  
Data, Time Frame, and Discrepancies of the Data Set 
After receiving IRB approval (09-04-20-0492934) from Walden University, the 
deidentified data were analyzed using the IBM Statistical Package for the Social Sciences 
version 25 (SPSS). The secondary data obtained for this study was acquired from an 
electronic data source through the CMS. In gathering data for the COPD readmissions 
and mortality rates, the initial sample size for the secondary data sets were comprised of 
38 
 
68,293 readmission and mortality rates for both non-VA and VA hospitals as well as for 
other diseases and illnesses such as acute myocardial infarction, pneumonia, diabetes, 
during 2016–2019.  
After exclusions, the COPD readmission and mortality data totaled 4,879. The 
data were deidentified in an Excel spreadsheet. Data sets were first filtered by the specific 
intent of readmission, mortality rates, and VA hospitals. Information was then filtered by 
state excluding the District of Columbia, Puerto Rico, and the Philippines because they 
are not considered states within the United States.  
Study Results 
After completing the collection, organization, and description of the secondary 
data set, statistics and hypothesis testing were performed to test for relationships within 
the secondary data set. The statistical tests used for this study were independent t tests, 
ANOVA tests, and linear regression. The independent t test is often used to compare the 
means of two groups, which can be done through parametric or nonparametric statistical 
inference (Tae, 2015). One-way ANOVA testing is used for evaluation of three or more 
groups of continuous data (Nawi et al., 2020). Significant differences between subgroups 
of the study are accomplished by using multiple comparison analysis. The ANOVA helps 
to decrease the chance of a type 1 error, which is falsely concluding significance when 
there is no real effect present. The ANOVA was appropriate in this study because it has 
been used in similar studies to determine whether one treatment is more effective than 
another in a certain sample population. By applying ANOVA testing to secondary data 
sets, the researcher can determine the differences among groups (Prel et al., 2010). 
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Further, a basic but reliable and commonly used predictive analysis is the linear 
regression test. This test is a process of pinpointing which variable or variables have 
impact on a specific topic. Performing a regression determines which factors matter the 
most and which factors can be ignored as well as how the factors can influence one 
another (How to Statistics, 2018). Regression tests can be used to identify the strength of 
the effect that the independent variable or variables have on a dependent variable, to 
forecast effects or impact of changes, and to predict trends and future values. The type of 
linear regression used for this study was a simple linear regression which is one 
dependent variable (interval or ratio), and one independent variable (interval or ratio or 
dichotomous).  
Research Question 1   
Is there a significant difference between COPD mortality rates for veterans in the 
VA Pacific District, VA Continental District, VA Northeast District, and VA Southeast 
District?  
One-Way ANOVA Testing 
Research Questions 1 and 2 were analyzed by utilizing the one-way ANOVA 
testing. ANOVA is a hypothesis-based test that test equality among two or more groups 
and examines if the differences in sample populations are due to error or if there are 
specific causes leading to the differences in the sample population. In accordance with 
the one-way ANOVA analysis, data collected will either prove or disprove the null 
hypothesis that all three determinants on average, produce the same response. One-way 
ANOVA testing is reliable under the following assumptions: (a) variances among the 
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sample populations are equal, (b) responses for groups are independent and identically 
dispersed, and (c) response variables are typically distributed (Mackenzie, 2018). 
Hospitals were divided into four separate districts according to the U.S. Department of 
Veterans Affairs.  
As shown in Table 3, the data elements represent direct variable information for 
mortality rates of the geographical districts participating hospitals (n = 177) for the 
January 1, 2016 through June 30, 2019. The participating VA hospitals within the VA 
Pacific district is (n = 21), VA Continental district is (n = 17), VA Northeast district is (n 
= 44), and the VA Southeast district is (n = 35). Mean values for the VA Pacific district = 
8.01, VA Continental district = 8.5, VA Northeast district = 7.94, and VA Southeast 
district = 8.24. The total mean score for all districts = 8.12. To see if a difference in mean 
scores reaches significance, see Table 4.      
Table 3 
 
One-Way ANOVA for COPD Mortality Rates in each VA District 
Districts n Mean SD  SE   95% CI Mean                    
     Lower Bound     Upper Bound Min Max 
VA  
Pacific 
21 8.0119 1.18553 .25870        7.4723               8.5516 5.90 9.85 
VA 
Continental 
17 8.5235 1.19545 .28994        7.9099               9.1382 6.40 10.70 
VA 
Northeast 
44 7.9364 1.01846 .15354        7.6267               8.2460 6.15 10.35 
VA 
Southeast 
35 8.2413 .83009 .14031        7.9291               8.4994 6.60 10.00 






Tests of Homogeneity of Variances 
Ave. _30 
D 
 Levene Statistic df1 df2 Sig. 
 Based on Mean 1.669 3 113 .178 
 Based on Median .997 3 113 .397 
 Based on Median and with 
adjusted df 
.997 3 98.042 .397 
 Based on trimmed mean 1.647 3 113 .183 
 
The test of homogeneity of variances was performed to see if the variances in 
each of the four VA districts were equal. This was done with what is known as the 
Levene statistics, where the researcher is looking at the significant value to see if it is 
greater than .05 (How To Statistics, 2018). Levene statistics based on a comparison of 
medians in this study is .397. This is not a significant result, the test of homogeneity of 
variance was met, and the ANOVA test can be considered strong.  
Tukey HSD and Games-Howell post HOC test were also performed to examine 
which, if any, mean differences there are between the groups being examined. Table 5 
shows the significant values were above the standard .05 alpha level for all groups. The F 
value is used to determine whether a test was considered to be statistically significant by 
dividing two mean squares. The F value in this test was checked to see whether this 
reaches significance. The value of F is 1.522, which reaches the significance with a p-







      
 Sum of     
Average_30D Squares Df Mean Square F Sig 
Between Groups 4.808 3 1.603 1.522 .213 
Within Groups 119.005 113 1.053   




Post-HOC Test Results 
 I District J District Mean 
Difference 
(I-J) 




















  Northeast .07554 .27218 .992 -.6342 .7853 
  Southeast -20238 .28327 .891 -.9410 .5363 
 Continental Pacific .51162 .33481 .424 -.3615 1.3847 
  Northeast .58717 .2930 .193 -.1770 1.3514 
  Southeast .30924 .30338 .738 -.4819 1.1004 
 Northeast Pacific .07554 .27218 .992 .7853 .6342 
  Continental .58717 .29306 .193 -1.3514 .1770 
  Southeast .57792 .23243 .631 -.8840 .3282 
 Southeast Pacific .20238 .28327 .891 -.5363 .9410 
  Continental .30924 .30338 .738 -1.1004 .4819 

















  Northeast .07554 .30083 .994 -.7363 .8874 
  Southeast -.20238 .29430 .901 -.9999 .5952 
 Continental Pacific .51162 .38858 .559 -.5375 1.5607 
  Northeast .58717 .32808 .301 -.3141 1.4884 
  Southeast .30924 .32211 .773 -.5800 1.1985 
 Northeast Pacific -.07554 .30083 .994 -8874 .7363 
  Continental -.58717 .32808 .301 -1.4884 .3141 
  Southeast -.27792 .20799 .543 -.8241 .2683 
 Southeast Pacific -.20238 .29430 .901 -.5952 .9999 
  Continental -.30924 .32211 .773 -1.1985 .5800 




The homogenous subset was then evaluated to see which groups have the same 
mean and which have different means. Again, each group was above the standard .05 
alpha level for all groups. The predictor was the mortality rate, and the outcome was the 
30-day average (see Table 7).  
Table 7 
 
Homogenous Subsets Results 
 District N            Subset for 
Alpha = 0.05 
1 
Tukey HSD Northeast 44 7.9364 
 Pacific 21 8.0119 
 Southeast 35 8.2143 
 Continental 17 8.5235 
 Sig  .181 
 
The analysis resulted in no statistically significant difference between groups as 
determined by the one-way ANOVA [F (3,113) =1.522, p < 0.05]. A Tukey post hoc 
revealed that the COPD mortality rates between the VA Pacific District and VA 
Continental District [8.25, 95% CI (7.91, - 9.14) p < 0.05], VA Northeast District [7.94, 
95% CI (7.63, - 8.25) p = < 0.05], and VA Southeast District [8.24, 95% CI (7.93, - 8.50) 
p = < 0.05]. Therefore, Research Question 1’s results showed no statistical difference 
between mortality rates within the four United States VA regions, accepting the null 
hypothesis: There is no significant difference between COPD mortality rates for veterans 
in the VA Pacific District, VA Continental District, VA Northeast District, and VA 
Southeast District.   
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Research Question 2 
Is there a significant difference between COPD readmission rates for veterans in 




COPD Readmission Rates for Veterans in the Four VA Districts  
Districts n Mean SD  SE  95% CI Mean                    
     Lower Bound     Upper Bound Min Max 
VA  
Pacific 
22 19.8727 1.50766 .32143        19.2043            20.5412 17.05 23.90 
VA 
Continental 
17 19.8000 1.29940 .31515        19.1319            20.4681 18.10 22.60 
VA 
Northeast 
45 20.3800 1.23456 .18404        20.0091            20.7509 17.75 23.25 
VA 
Southeast 
37 20.2311 1.89957 .31229        19.5977             20.8644 16.80 26.90 
Totals 121 20.1607 1.52232 .13839        19.8867             20.4348 16.80 26.90 
 
Table 8 shows the readmission rates of the geographical districts participating 
hospitals (n = 121) for the specific time frame Jan. 1, 2016 through June 30, 2019. The 
participating VA hospitals within the VA Pacific district is (n = 22), VA Continental 
district is (n = 17), VA Northeast district is (n = 45), and the VA Southeast district is (n = 
37). Mean values for the VA Pacific district = 19.87, VA Continental district = 19.80, 
VA Northeast district = 20.40, and VA Southeast district = 20.23. The total mean score 
for all districts = 20.20. To see if a difference in mean scores reaches significance, a test 
of homogeneity variances is examined (see Table 11). 
Table 9 
 
Test of Homogeneity of Variances Results for 30 Day Readmission Rates 
Ave. _30 
D 
 Levene Statistic df1 df2 Sig. 
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 Based on Mean 1.497 3 117 .219 
 Based on Median 1.065 3 117 .367 
 Based on Median and with 
adjusted df 
1.065 3 88.643 .368 
 Based on trimmed mean 1.356 3 117 .260 
 
The test of homogeneity of variances was done to see if the variances in each of 
the four VA districts were equal and if the significant value is greater than .05. This was 
done with what is known as the Levene Statistics. The Levene statistic based on a 
comparison of medians is 1.065. The test of homogeneity of variance was met, and the 
ANOVA test can be considered strong. The F value allow is then checked to see whether 
this reaches significance. The value of F is .916, which reaches the significance with a p-
value of .435 (see Table 10).  
Table 10 
 
One-Way ANOVA Results for 30 Day Readmission Rates 
 Sum of     
Average_30D Squares Df Mean Square F Sig 
Between Groups 6.384 3 2.128 .916 .435 
Within Groups 271.712 117 2.322   




Post-HOC Results for 30 Day Readmission Rates 





I District J District Mean 
Difference 
(I-J) 




















   Northeast -.50727 .39644 .578 -1.5405 .5260 
   Southeast -.35835 .41028 .819 -1.4277 .7110 
  Continental Pacific -.07273 .49211 .999 -1.3553 1.2099 
  Northeast -.58000 .43384 .541 -1.7107 .5507 
  Southeast -.43108 .44651 .769 -1.5948 .7327 
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 Northeast Pacific .50727 .39644 .578 -.5260 1.5405 
  Continental .58000 .43384 .541 -.5507 1.7107 
  Southeast .14892 .33819 .971 -.7325 1.0304 
 Southeast Pacific .35835 .41028 .819 -.7110 1.4277 
  Continental .43108 .44651 .769 -.7327 1.5948 

















  Northeast -.05727 .37039 .526 -1.5059 .4913 
  Southeast -.35835 .44816 .854 -1.5476 .8309 
 Continental Pacific -.07273 .38858 .998 -1.2843 1.1388 
  Northeast -.58000 .36495 .401 -1.5773 .4173 
  Southeast -.43108 .44367 .766 -1.6157 .7535 
 Northeast Pacific .50727 .37039 .526 -.4913 1.5059 
  Continental .58000 .36495 .401 -.4173 1.5773 
  Southeast .14892 .36248 .976 -.8092 1.1070 
 Southeast Pacific .35835 .44816 .854 -.8309 1.5476 
  Continental .43108 .44367 .766 -.7535 4.6157 
  Northeast -.14892 .36248 .976 -1.1070 .8092 
 
Tukey HSD and Games-Howell post HOC test was then analyzed to see examine 
which, if any mean differences there are between the groups being examined. Significant 
values were above the standard .05 alpha level for all groups (see Table 12). 
Table 12 
 







       Subset for 
Alpha = 0.05 
1 
Tukey HSD Continental 17 19.8000 
 Pacific 22 19.8727 
 Southeast 37 20.2311 
 Northeast 45 20.3800 
 Sig  .518 
 
The homogenous subset was then evaluated to see which groups have the same 
mean and which have different means. Again, each group was above the standard .05 
alpha level for all groups. The predictor was the mortality rate, and the outcome was the 
30-day average.  
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The analysis resulted in a statistically significant difference between groups as 
determined by the One-way ANOVA [F (3,117) =1.522, p < 0.05]. A Tukey post hoc 
revealed that the COPD mortality rates between the VA Pacific District and VA 
Continental District [.073, 95% CI (-1.21, - 1.36) p < 0.05], VA Northeast District [.358, 
95% CI (-1.54, - .526) p = < 0.05], and VA Southeast District [.358, 95% CI (-1.428, - 
.711) p = <0.05].  
This is not a statistically significant result, subsequently there is no difference in 
COPD readmission rates between the four VA regions within the U.S. Districts therefore 
accepting the null hypothesis: There is no significant difference between COPD 
readmission rates for veterans in the VA Pacific District, VA Continental District, VA 
Northeast District, and VA Southeast District. 
Research Question 3 
Is there a significant geographical influence for COPD readmission rates of 
veterans in urban and rural VA hospitals? For urban hospitals, N = 105, Mean = 20.1833, 
SD = 1.56599, and SE = .15283. For rural hospitals, N = 16, Mean = 20.0125, SD = 
1.22875, and SE = .30719. See Table 13 for the t test results.  
Table 13 
 
Independent Samples t test for Readmission Rates in Urban Versus Rural Hospitals  
   t test for equality of means 




      95% Confidence Interval 
of the difference 
 
 




SD Lower Upper 
           
48 
 
Ave_30D Equal          
 variances .0001 .977 -2.041 115 .044 .57539 .28182 -1.13373 -0.1706 
 assumed          
 Equal          
 variances   -2.046 18.393 .055 .57539 .28124 -.1.16534 -.01456 
 Not 
assumed 
         
 
To investigate if there was a significant geographical influence for COPD 
readmission rates of veterans in urban and rural VA hospitals an independent sample t-
test was performed. The urban hospitals group (n = 105) associated with COPD 
readmissions (M = 20.18, SD = 1.57, n = 105). By comparison, the rural hospital groups 
(n = 16) COPD readmissions (M = 20.01, SD = 1.23, n = 16) was associated with 
numerically similar means. The significance level was .977 and the variances are 
assumed equal. The Sig. (2-tailed) score was lower than 0.05, meaning there is significant 
difference between the mean scores. Results of the independent samples t-test showed 
that the mean readmission rates of urban (M = 20.18, SD = 1.57, n = 105) and 
readmission rates of rural (M = 20.01, SD = 1.23, n = 16) was not statistically significant 
at the .05 level of significance (t (115) = -2.041, df = 115, p >.05). The independent 
samples t-test suggests there was no significant difference in the mean COPD 
readmissions between urban or rural hospitals, therefore accepting the null hypothesis: 
There is not a significant geographical influence with COPD readmission rates for 
veterans in urban and rural VA hospitals.   
Research Question 4 
Is there significant geographical influence with COPD mortality rates for veterans 
in urban and rural hospitals? To investigate if there was a significant geographical 
influence for COPD mortality rates of veterans in urban and rural VA hospitals an 
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independent sample t test was performed. For urban hospitals, N = 10, Mean = 8.0446, 
SD = 1.01968, and SE = .10096. For rural hospitals, N = 15, Mean = 8.6200, SD = 
1.01661, and SE = .26249 
Table 14 
 
Independent Samples t test for Mortality Rates in Urban Versus Rural Hospitals  
   t test for equality of means 




      95% Confidence Interval 
of the difference 
 
 




SD Lower Upper 
           
Ave_30D Equal          
 variances 1.323 .252 .417 119 .678 .17083 .40996 -.64094 .98260 
 assumed          
 Equal          
 variances   .498 23.140 .623 .17083 .34310 -.53869 .88036 
 Not 
assumed 
         
   
The urban hospitals group (n = 102) associated with COPD mortalities (M = 
8.0446, SD = 1.02, n = 102). By comparison, the rural hospital groups (n = 15) COPD 
mortalities (M = 8.6200, SD = 1.02, n = 15) was associated with numerically similar 
means. The significance level was .252 and the variances are assumed equal. The top line 
of the results in table 16 shows the Sig. (2-tailed) score is higher than 0.05 therefore there 
is significant difference between the mean scores. Results of the independent samples t-
test showed that the mean mortality rates of urban (M = 8.0446, SD = 1.02, n = 102) and 
mortality rates of rural (M = 8.6200, SD = 1.23, n = 15) was statistically significant at the 
.05 level of significance (t (115) = -2.041, df = 115, p >.05).  
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Research question 4 results show the independent samples t-test suggests there 
was significant difference in the mean COPD mortality rates between urban or rural 
hospitals, therefore rejecting the null hypothesis and accepting the alternative hypothesis: 
There is a significant geographical influence with COPD mortality rates for veterans in 
urban and rural VA hospitals.  
Research Question 5 
Is there an association between 30-day readmission rate for COPD and the 30-day 
mortality rate? To investigate if there was an association between 30-day readmission 
rate for COPD and the 30-day mortality rates a linear regression was conducted. See 
Table 15 for the regression results. See Tables 16–19 for the model summary, ANOVA, 
correlation results, and coefficients, respectively.  
Table 15 
 





  Mortality_30D Average_Read 
Mission_30D 
Pearson Correlation Mortality_30D 1.000 -.263 
 Average_Readmission_30D -.263 1.000 
Sig. (1-tailed) Mortality_30D  .002 
 Average_Readmission_30D .002  
 Mortality_30D 117 117 
 Average_Readmission_30D 117 117 
 
 Mean SD N 
Mortality 30D 8.1184 1.03313 117 






        Change Statistics 
          
  R Adjusted R Std. Error of R Square F   Sig. F 
Model R Square Square the Estimate Change Change df1 df2 Change 
1 .263a .069 .061 1.001.3 .069 8.559 1 115 .004 








   










1 Regression  8.576 1 8.576 8.559 004b 
 Residual  115.237 115 1.002   
 Total  123.813 116    
a. Dependent Variable: Mortality_30D 









1 (Constant) 11.684 1.222  9.558 .000 9.263 14.106 
 Average_Readmission -.177 .060 -.263 -2.926 .004 -.296 -.057 
 30D        
a. Dependent Variable: Mortality_30 Day 
The predictor was the average of 30-day COPD readmissions, and the outcome 
was the average mortality rates. The predictor was found to be statistically significant [B 
= 11.684, 95% C.I. (aa, bb), p < .05], indicating that for everyone unit increase in the 
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average 30-day readmissions, the mortality rates changed by (-) 1.77 units. The model 
explained approximately (R-squared * 100%) of the variability [R – squared = .069].  
The results for research question 5 show there is association between the 
readmission rates and mortality rates for COPD. Therefore, the null hypothesis is 
rejected, and the alternative hypothesis is retained: There is association between 30-day 
readmission rate for COPD and the 30-day mortality rate.  
Summary 
Results and findings of the analysis of the five research questions were presented 
in section 3, including the data collection plan, data exclusions, data inclusions, 
descriptive statistics, and inferential statistics. Statistics applied in the study were one-
way anovas, t-tests, and linear regression. Analyses of the hypotheses and research 
questions and any key findings were included. This study examined if an association 
between COPD readmissions and mortality rates specifically examining the relationship 
between rural and urban VA hospitals within the four VA regions within the United 
States. Section 4 includes the analysis and understanding of the results, limitations of the 
study, recommendations for further research, and implications concerning 30-day COPD 
readmissions and social change. 
In conclusion findings indicated there was no significant difference when 
examining COPD mortality rates between the 4 U.S. VA regions. There was no 
significant difference when examining COPD readmission rates between the 4 U.S. VA 
regions. There was no significant difference when examining COPD readmission rates 
between urban and rural VA hospitals. Findings indicated significant difference upon 
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assessing the COPD mortality rates between urban and rural VA hospitals with results 
showing higher mortality rates among urban VA hospitals, rather than rural hospitals. 
Finally, when taking all of the COPD population and comparing the COPD readmission 
rates against COPD mortality rates results indicated there was a significant difference 





Section 4: Application to Professional Practice and Implications for Social Change  
The purpose of this nonexperimental, quantitative, relationship study was to 
determine whether there was an association between COPD readmissions and mortality 
rates within the rural and urban hospitals in the four U.S. VA regions. To bring even 
more value to the study, geographical influence between rural and urban VA hospitals 
were examined as well as the influence of COPD readmissions on mortality rates. This 
study was strong due to robust and ethical evidence as well as time based, realistic 
settings. Given the multiple reasons and results of COPD readmissions and mortality 
rates for both rural and urban VA hospitals within the four U.S. geographical districts, 
these findings may be used to ensure patients, physicians, COPD navigators, respiratory 
therapists, and nurses continue to partner for solutions to improved, healthier outcomes 
for this complex disease. Section 4 includes an interpretation of the findings, limitations 
of the study, recommendations for further research, and implications for professional 
practice and social change. 
Interpretation of Results      
Research Question 1: COPD Mortality Rates for Veterans in the VA Pacific 
District, VA Continental District, VA Northeast District, and VA Southeast District 
The analysis resulted in no statistically significant difference between groups as 
determined by the one-way ANOVA [F (3,113) = 1.522, p < 0.05]. A Tukey post hoc 
revealed that the COPD mortality rates between the VA Pacific District and VA 
Continental District [8.25, 95% CI (7.91, - 9.14) p < 0.05], VA Northeast District [7.94, 
95% CI (7.63, - 8.25) p < 0.05], and VA Southeast District [8.24, 95% CI (7.93, - 8.50) p 
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< 0.05]. There was no statistical significance between the COPD mortality rates for 
veterans in the VA Pacific District, VA Continental District, VA Northeast District, and 
VA Southeast District (p =.213). Therefore, the null hypothesis was accepted, indicating 
no difference in COPD mortality rates between the four VA regions within the U.S. 
districts. 
Research Question 2: COPD Readmission Rates for Veterans in the VA Pacific 
District, VA Continental District, VA Northeast District, and VA Southeast District 
The analysis shows no statistically significant difference between groups as 
determined by the one-way ANOVA [F (3,117) =1.522, p < 0.05]. A Tukey post hoc 
revealed that the COPD readmissions rates between the VA Pacific District and VA 
Continental District [.073, 95% CI (-1.21, - 1.36) p < 0.05], VA Northeast District [.358, 
95% CI (-1.54, - .526) p < 0.05], and VA Southeast District [.358, 95% CI (-1.428, - 
.711) p < 0.05]. There was no statistical significance between the COPD readmission 
rates for veterans in the VA Pacific District, VA Continental District, VA Northeast 
District, and VA Southeast District (p =.435). Therefore, null hypothesis was accepted, 
indicating no difference in COPD readmission rates between the four VA regions within 
the U.S. districts. 
Research Question 3: Geographical Influence for COPD Readmission Rates of 
Veterans in Urban and Rural VA Hospitals 
Results of the independent samples t test showed that the mean readmission rates 
of urban (M = 20.18, SD = 1.57, n = 105) and readmission rates of rural (M = 20.01, SD = 
1.23, n = 16) was not statistically significant at the .05 level of significance (t (115) = -
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2.041, df = 115, p > .05). The independent samples t test suggests there was no significant 
difference in the mean COPD readmissions between urban or rural hospitals, therefore 
accepting the null hypothesis. Thus, there is not a significant geographical influence with 
COPD readmission rates for veterans in urban and rural VA hospitals.    
Research Question 4: Geographical Influence with COPD Mortality Rates for 
Veterans in Urban and Rural Hospitals 
Results of the independent samples t test showed the mean mortality rates of 
urban (M = 8.0446, SD = 1.02, n = 102) and mortality rates of rural (M = 8.6200, SD = 
1.23, n = 15) was statistically significant at the .05 level of significance (t (115) = -2.041, 
df = 115, p > .05). Research Question 4 results show the independent samples t test 
suggest there was significant difference in the mean COPD mortality rates between urban 
or rural hospitals, therefore rejecting the null hypothesis. Thus, there is a significant 
geographical influence with COPD mortality rates for veterans in urban and rural VA 
hospitals.  
Research Question 5: Association Between 30-Day Readmission Rate for COPD and 
the 30-Day Mortality Rate Between Urban and Rural VA Hospitals 
The predictor was found to be statistically significant [B = 11.684, 95% CI (aa, 
bb), p < .05], indicating that for every 1 unit increase in the average 30-day readmissions, 
the mortality rates changed by (-) 1.77 units. The model explained approximately (R-
squared * 100%) of the variability [R – squared = .069]. The results for Research 
Question 5 show that there is association between the readmission rates and mortality 
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rates for COPD, as mortality rates actually increased in relation to readmission rates. 
Therefore, the null hypothesis is rejected. 
Findings Related to Literature 
Findings indicated that there was no significant difference when examining 
COPD mortality rates or COPD readmission rates between the four U.S. VA regions. 
Outcomes also suggested that there was no significant difference when examining COPD 
readmission rates between urban and rural VA hospitals; however, findings did support 
that there was a significant difference upon assessing the COPD mortality rates between 
urban and rural VA hospitals with results showing higher mortality rates among urban 
VA hospitals, rather than rural hospitals. Finally, results indicated that there was a 
significant difference between COPD readmissions and COPD mortality rates, but 
instead of COPD mortality rates being higher due to COPD readmissions, for every 1 unit 
decrease in the average 30-day readmissions, the mortality rates changed by (-) 1.77 units 
indicating that mortality rates actually increased. 
As discussed in the literature review, COPD mortality and readmission rates are 
among the higher categories for illness and disease within healthcare in both VA and 
non-VA hospitals. The VHA works in partnership with the CMS to provide patients 
information about the quality and safety of the care received (CMS, 2016). COPD was 
added to the Medicare Hospital Readmission Reductions Program in 2015, resulting in 
financial penalties for COPD readmissions within 30 days of hospital discharge (Portillo, 
et al., 2018). Researchers in past studies reported VA health care systems perform similar 
to or better than non-VA systems concerning inpatient and outpatient measures involving 
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care quality, despite variation in quality across individual VA facilities (Price et al., 
2018). In another study, variations in quality across VA facilities was identified as factors 
like quality-of-care culture of data collection, feedback, and behavior change, as well as 
process-of-care measures (Segal et al., 2019). This information is found to align with this 
research study due to understanding that while the VA hospitals are systemized there are 
many variables outside of those practices and processes which can possibly impact 
readmissions or mortality rates. As shown in the literature review, the Andersons 
Behavioral Model, Figure 1 was a perfect model for this study to show in showing a 
framework of how environmental factors can impact a patient’s behaviors and outcomes. 
Upon observation of VA hospitals, it was noticed that many or most VA hospitals have 
had a name change and many had several name changes which could make it difficult 
when data is being retrieved. Targeted quality focused improvement efforts to ensure 
veterans receive high-quality care at all VA facilities, uniform care at all VA facilities, 
older aged patients or sicker patients being transferred or transported to specific VA 
facilities which have the ability to care for higher acuity. 
Urban Versus Rural VA Hospitals    
In one study, researchers found an association of rural residence with a risk of 
COPD exacerbations requiring treatment (Burkes, et al, 2018). Again, the Andersons 
Behavioral Model, Figure 1 was a perfect model showing a framework of how 
environmental factors can impact a patient’s behaviors and outcomes. This study found 
when examining rural and urban VA hospitals there was no significance found for COPD 
readmissions but found a significant difference for COPD mortality rates showing an 
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increase in urban VA hospitals. Possible reasons for this increase in mortality could be 
higher acuity, staffing ratios, increased patient census, other co-morbidities contributing 
to or causing death. Other possibilities for an increase in mortality could be due to 
socioeconomics, educational needs, or no transportation or access to care.  
Readmissions and Mortality Rates Between Contributing Rural and Urban VA 
Hospitals 
The results for research question 5 show there is association between the 
readmission rates and mortality rates for COPD. Findings showed for every 1 unit 
increase in the average 30-day readmissions, the mortality rates changed by (-) 1.77 units. 
Again, the Andersons Behavioral Model, Figure 1 was an ideal model for this study to 
show a framework of how environmental factors can impact a patient’s behaviors and 
outcomes. Possible reasons for the decrease in mortality rates is due to better education 
being provided to patients by providers, patients going to the hospital upon onset of signs 
or symptoms of problems with COPD, patients being transferred to higher acuity 
facilities when appropriate, CMS withholding reimbursement to facilities with high 
readmission numbers.  
Findings Related to the Andersen Healthcare Utilization Model 
The primary conceptual framework for this study was the Andersen Healthcare 
Utilization Model which seeks to clarify factors that identify how individuals access 
health services (Babitsch, Gohl, & von Lengerke, 2012; Hirshfield, Downing, Horvath, 
Swartz, & Chiasson, 2016). The four factors of this Model are environment, population 
characteristics, health behaviors, and outcomes (Babitsch, et al., 2016). The Andersen 
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model is frequently used for healthcare studies and is used to theorize that patient 
outcomes are influenced either positively or negatively by their environment, population 
characteristics, health behaviors and outcomes. In this study the region or type of VA 
hospital would be considered the patient’s environment which could contribute to a 
patient’s outcome. 
Summary of Key Findings and Interpretation 
The quantitative outcome of this research study demonstrates there is no statistical 
difference between COPD mortality rates for veterans in the VA Pacific District, VA 
Continental District, VA Northeast District, and VA Southeast District. In Addition, 
findings observed there was not statistical difference between COPD readmission rates 
for veterans in the VA Pacific District, VA Continental District, VA Northeast District, 
and VA Southeast District. Furthermore, this research study affirms there is no 
geographical influence for COPD readmission rates of veterans in urban and rural VA 
hospitals. Additionally, findings show there is statistical significant difference between 
mortality rates between rural and urban VA hospitals as well as an association between 
30-day readmission rates for COPD and the 30-day mortality rate between urban and 
rural VA hospitals when considering the overall VA population within this study. 
Limitations of the Study     
There were limitations in the research data set that influenced generalizability, 
validity, and reliability of the findings. Marshall and Rossman (2016) state that 
limitations are inadequacies of the study that could not be controlled by the researcher. 
Limitations found pertained to the secondary information used for this study was 
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complicated to sort through. Information from the CMS data set utilized was gathered 
between 2016 through 2019. The actual number of sample size was not available until 
data had been downloaded and filtered eliminating other disease readmissions and 
mortality statistics. Secondary data obtained did not give insight to gender, ages, other 
comorbidities, patient education levels, or information about the VA facilities. In 
retrospect, more VA hospitals participating in research studies and submitting data might 
have changed the outcomes of this study.  
Recommendations for Future Research 
Results of this research study reveal opportunities for future research. Hospital 
collection of data and participation in research studies is critical in adding to future 
research. In addition, research could be further expanded within the VA COPD 
readmission and mortality rates and additional factors impacting readmissions and 
mortality rates. Additional opportunities for research would be healthcare worker 
recognition of signs and symptoms in a timely manner to see if patients are treated with 
better procedures or therapy due to faster acknowledgement of COPD signs and 
symptoms. Additional research prospects would include researching patient education 
and teaching techniques between rural and urban VA hospitals. Types of equipment 
between rural and urban VA hospitals could be researched to rule out readmission and 
mortality rates due to the lack state of the art equipment sometimes seen at rural facilities. 
Other research focus could be on the disease itself and its severity stage or a timeline of 
interventions provided to patients. Information provided within this study provides 
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knowledge to healthcare administrators and providers opportunities to work together as a 
team to create and encourage better research opportunities. 
Social Change 
COPD is globally one of the most common respiratory diseases among adults in 
the US and represents between 5.1 and 6.2% of the overall adult population and in the 
Veteran population, COPD is even higher ranking at 8.8% (Pyarali, Schweitzer, Bagley, 
Salamo, Guerrero, Sharifi, Mirsaeidi, 2018). Being able to reduce hospital visits and 
inpatient stays of patients with COPD is an important approach which is important to 
lowering readmissions, mortality, and higher healthcare costs. This study demonstrates 
there is a standardization within VA regions and similarity in care between rural and 
urban VA hospitals with COPD readmissions and mortality rates.  
Currently, hospitals are being financially penalized for excessive readmissions for 
patients diagnosed with COPD. The Centers for Medicare & Medicaid Services considers 
COPD readmissions to be preventable (Mayr, Talisa, Balakumar, Chang, Fine, & Yende, 
2017). As financial penalties continue to be imposed, this study may assist health care 
administrators in understanding some components and potential strategies of hospital 
readmissions for COPD patients and better patient outcomes.  
Results of this study showed for every decrease for readmissions there was an 
increase in mortality rates when examining both urban and rural VA hospitals. This is 
important to social change because focus can be given to variables influencing the 
mortality rates of COPD patients. For instance, are patients waiting too long to go to 
facilities or are facilities transferring patients to higher acuity hospitals in time?  
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This study encourages social change by adding transparency to the relationship 
between VA hospital readmissions and mortality rates between VA hospitals within the 
four U.S. VA districts. Healthcare providers and administrators have a responsibility to 
seek ways to decrease patient readmissions and mortality rates and to continually to 
provide better education, tests, procedures, therapy, and medications to patients. Future 
studies concerning VA hospitals and COPD readmissions and mortality rates among the 
veteran population are important.   
Conclusion 
This study identified the relationships between COPD readmissions and mortality 
rates among VA hospitals within the U.S. districts. Gathering more data, encouraging 
more hospital participation, expanding the focus into patient behaviors, and examining 
other possible factors such as age, gender, or a timeline of interventions are important 
ways to further COPD readmission and mortality research. Overall, this study addressed 
the gap in the literature regarding the relationship between COPD readmissions and 
mortality rates among the U.S. urban and rural VA hospitals. Results of this study 
concluded there were no differences between U.S. districts or among readmissions rates 
between urban and rural VA hospitals, but showed there were differences between 
mortality rates between urban and rural VA hospitals. Lastly, hospital administrators may 
refer to this study to focus on managing matters which may impact COPD readmissions 
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